Mr. Gomez, who became Moderna’s CFO on May 9, left the company May 10 after his former employer, Dentsply Sirona, disclosed it was launching an internal probe into financial reporting. Mr. Gomez had served as CFO of Dentsply Sirona since 2019.
Dentsply Sirona, which manufactures dental products and technology, said it will not file its quarterly report with the Securities and Exchange Commission because of the investigation.
Under the separation agreement, Moderna will pay Mr. Gomez the $700,000 severance in biweekly installments, unless he is found to have engaged in any wrongdoing related to the investigation by Dentsply Sirona. If he is required to pay a fine, penalty or disgorgement, the company will claw back the severance pay.
Although Moderna promised severance, Mr. Gomez forfeited his $500,000 signing bonus, according to The Wall Street Journal.
Access the full separation agreement here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
